These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 16485364)

  • 1. A modest proposal to amend the Patent Code 35 U.S.C. Section 287(c) to allow health care providers to examine their patients' DNA.
    Minwalla S
    South Ill Univ Law J; 2002; 26(3):471-504. PubMed ID: 16485364
    [No Abstract]   [Full Text] [Related]  

  • 2. Much ado about gene patents: the role of foreseeability.
    Gulliford MJ
    Seton Hall Law Rev; 2004; 34(2):711-45. PubMed ID: 15115032
    [No Abstract]   [Full Text] [Related]  

  • 3. Gene patent policy: does issuing gene patents accord with the purposes of the U.S. patent system?
    Bradshaw J
    Willamette Law Rev; 2001; 37(4):637-60. PubMed ID: 12774776
    [No Abstract]   [Full Text] [Related]  

  • 4. Patent law and human genome research at the crossroads: the need for Congressional action.
    McKay DL
    Santa Clara Comput High Technol Law J; 1994; 10(2):465-98. PubMed ID: 16514752
    [No Abstract]   [Full Text] [Related]  

  • 5. Patents. U.S. appeals court hears gene patent arguments.
    Marshall E
    Science; 2012 Jul; 337(6092):277-8. PubMed ID: 22822118
    [No Abstract]   [Full Text] [Related]  

  • 6. DNA as patentable subject matter and a narrow framework for addressing the perceived problems caused by gene patents.
    Schilling SH
    Duke Law J; 2011 Dec; 61(3):731-73. PubMed ID: 22165443
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Diffuse rules on patent protection of genes. Scientists risk retroactive payment requirements].
    Orn P
    Lakartidningen; 2000 Nov; 97(46):5285-6. PubMed ID: 11116864
    [No Abstract]   [Full Text] [Related]  

  • 8. European opposition to exclusive control over predictive breast cancer testing and the inherent implications for U.S. patent law and public policy: a case study of the Myriad Genetics' BRCA patent controversy.
    Paradise J
    Food Drug Law J; 2004; 59(1):133-54. PubMed ID: 15190928
    [No Abstract]   [Full Text] [Related]  

  • 9. Genetic patents: gatekeeper to the promised cures.
    Westin LP
    Thomas Jefferson Law Rev; 2002; 25(1):271-99. PubMed ID: 15164741
    [No Abstract]   [Full Text] [Related]  

  • 10. [Federal judge and government of the United States against gene patenting].
    Cassier M; Stoppa-Lyonnet D
    Med Sci (Paris); 2011; 27(6-7):662-6. PubMed ID: 21718652
    [No Abstract]   [Full Text] [Related]  

  • 11. Gene patents, health care policy and licensing schemes.
    Caulfield T; von Tigerstrom B
    Trends Biotechnol; 2006 Jun; 24(6):251-4. PubMed ID: 16621074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The scope of utility in the twenty-first century: new guidance for gene-related patents.
    Summers TM
    Georgetown Law J; 2003 Jan; 91(2):475-509. PubMed ID: 15046071
    [No Abstract]   [Full Text] [Related]  

  • 13. Procedure for gene patents.
    Blecher M
    Nature; 1993 Jan; 361(6409):199. PubMed ID: 8423844
    [No Abstract]   [Full Text] [Related]  

  • 14. Patenting of human genes, cells and parts of the body? -- the ethical dimensions of patent law.
    Moufang R
    IIC Int Rev Ind Prop Copyr Law; 1994; 25(4):487-515. PubMed ID: 11660161
    [No Abstract]   [Full Text] [Related]  

  • 15. Are human genes patentable?
    Sampson MJ
    Hastings Cent Rep; 2000; 30(4):4-5. PubMed ID: 10971884
    [No Abstract]   [Full Text] [Related]  

  • 16. The burgeoning science of genetics and the impact on public policy.
    Hatch OG
    J Biolaw Bus; 2004; 7(4):3-6. PubMed ID: 15675088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic testing of genetic disorders: limiting the scope of patent claims through disclosure requirements.
    Abbot J
    J Law Med; 2006 Aug; 14(1):110-26. PubMed ID: 16937785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Waiting on science: the stake of present and future patients.
    Quigley RB
    Am J Bioeth; 2002; 2(3):17-8. PubMed ID: 12230844
    [No Abstract]   [Full Text] [Related]  

  • 19. Whistling in the wind: patents on genetic research are a reality. It's time to reframe the debate.
    Caulfield TA; Gold ER
    Forum Appl Res Public Policy; 2000; 15(1):75-9. PubMed ID: 17333589
    [No Abstract]   [Full Text] [Related]  

  • 20. Genetics. Trends in human gene patent litigation.
    Holman CM
    Science; 2008 Oct; 322(5899):198-9. PubMed ID: 18845733
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.